Shankar Mythri, Gurusiddiah Sreedhara C, Nayaka Monika, Aralapuram Kishan
Department of Nephrology, Institute of Nephrourology, Bengaluru, Karnataka, India.
Indian J Nephrol. 2024 Jan-Feb;34(1):79-83. doi: 10.4103/ijn.ijn_252_22. Epub 2023 Mar 8.
Hemophagocytic lymphohistiocytosis (HLH) is a rare, life-threatening condition due to extensive and uncontrolled immune activation. There is sparse literature on HLH in kidney transplant recipients. We report a case of a 27-year -old male kidney transplant recipient who presented with dengue fever and acute allograft dysfunction. Following improvement in allograft function with supportive treatment, he was found to have worsening pancytopenia with unusually high serum ferritin levels. Bone marrow aspiration performed for pancytopenia revealed hemophagocytosis. A diagnosis of HLH secondary to dengue viral infection was made based on the modified HLH diagnostic criteria (2009). He received supportive treatment and steroids and was discharged in a stable condition with normal kidney allograft functions. To our knowledge, this is the first case report of HLH secondary to dengue viral infection in a kidney allograft recipient managed successfully with timely diagnosis and appropriate treatment.
噬血细胞性淋巴组织细胞增生症(HLH)是一种因广泛且不受控制的免疫激活导致的罕见的、危及生命的疾病。关于肾移植受者中HLH的文献较少。我们报告一例27岁男性肾移植受者,该患者出现登革热和急性移植肾失功。在支持治疗后移植肾功能改善,但发现他全血细胞减少加重且血清铁蛋白水平异常升高。因全血细胞减少进行的骨髓穿刺显示存在噬血细胞现象。根据改良的HLH诊断标准(2009年),诊断为登革病毒感染继发的HLH。他接受了支持治疗和类固醇治疗,出院时移植肾功能正常,病情稳定。据我们所知,这是首例关于肾移植受者中登革病毒感染继发HLH且通过及时诊断和适当治疗成功管理的病例报告。